Presentation of vitiligo in a case of COVID-19 infection concomitant with receiving remdesivir

Farideh Beyki; Saba Hasanzadeh; Fariba Ghalamkarpour

doi:10.1002/ccr3.8646

Presentation of vitiligo in a case of COVID-19 infection concomitant with receiving remdesivir

Clin Case Rep. 2024 Mar 11;12(3):e8646. doi: 10.1002/ccr3.8646. eCollection 2024 Mar.

Authors

Farideh Beyki¹, Saba Hasanzadeh^{1

2}, Fariba Ghalamkarpour^{1

2}

Affiliations

¹ Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
² Department of Dermatology, Shohada-e Tajrish Hospital Shahid Beheshti University of Medical Sciences Tehran Iran.

Abstract

The occurrence of vitiligo following COVID-19 infection and vaccination is well-documented. The mitochondrial dysfunction of melanocytes in vitiligo and the potential impact of RDV on mitochondria raise concerns about RDV possibly causing vitiligo.

Keywords: COVID‐19 infection; Vitiligo; remdesivir; vaccination.

Publication types

Case Reports